FI65911C - Oeverdrag som garanterar en kontrollerad frigoering av aktiva bestaondsdelar ur biologiskt aktiva preparat speciellt ur famaceutiska preparat och foerfarande foer framstaellning a v iologiskt aktiva preparat ur vilka aktiva bestaondsdelar ifroers kontrollerad - Google Patents

Oeverdrag som garanterar en kontrollerad frigoering av aktiva bestaondsdelar ur biologiskt aktiva preparat speciellt ur famaceutiska preparat och foerfarande foer framstaellning a v iologiskt aktiva preparat ur vilka aktiva bestaondsdelar ifroers kontrollerad Download PDF

Info

Publication number
FI65911C
FI65911C FI772719A FI772719A FI65911C FI 65911 C FI65911 C FI 65911C FI 772719 A FI772719 A FI 772719A FI 772719 A FI772719 A FI 772719A FI 65911 C FI65911 C FI 65911C
Authority
FI
Finland
Prior art keywords
aktiva
coating
polymer
preparat
organic solvent
Prior art date
Application number
FI772719A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI772719A (fi
FI65911B (fi
Inventor
Janos Dobo
Eszsebet Takacs
Gyoxo Hortobagyi
Nee Hajnoczy Marianne Skvorecz
Ilona Kolbe
Nee Vass Katalin Hoffmann
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of FI772719A publication Critical patent/FI772719A/fi
Application granted granted Critical
Publication of FI65911B publication Critical patent/FI65911B/fi
Publication of FI65911C publication Critical patent/FI65911C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI772719A 1976-09-17 1977-09-15 Oeverdrag som garanterar en kontrollerad frigoering av aktiva bestaondsdelar ur biologiskt aktiva preparat speciellt ur famaceutiska preparat och foerfarande foer framstaellning a v iologiskt aktiva preparat ur vilka aktiva bestaondsdelar ifroers kontrollerad FI65911C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HURI000596 1976-09-17
HU76RI596A HU174057B (hu) 1976-09-17 1976-09-17 Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva

Publications (3)

Publication Number Publication Date
FI772719A FI772719A (fi) 1978-03-18
FI65911B FI65911B (fi) 1984-04-30
FI65911C true FI65911C (fi) 1984-08-10

Family

ID=11001002

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772719A FI65911C (fi) 1976-09-17 1977-09-15 Oeverdrag som garanterar en kontrollerad frigoering av aktiva bestaondsdelar ur biologiskt aktiva preparat speciellt ur famaceutiska preparat och foerfarande foer framstaellning a v iologiskt aktiva preparat ur vilka aktiva bestaondsdelar ifroers kontrollerad

Country Status (20)

Country Link
US (1) US4267138A (fr)
JP (1) JPS6037093B2 (fr)
AT (1) AT355726B (fr)
AU (1) AU515157B2 (fr)
BE (1) BE858797A (fr)
CA (1) CA1110166A (fr)
CH (1) CH634748A5 (fr)
DD (1) DD137669A5 (fr)
DE (1) DE2741755C2 (fr)
DK (1) DK152831C (fr)
ES (1) ES462418A1 (fr)
FI (1) FI65911C (fr)
FR (1) FR2364660A1 (fr)
GB (1) GB1593062A (fr)
HU (1) HU174057B (fr)
IL (1) IL52936A (fr)
NL (1) NL7710182A (fr)
NO (1) NO148802C (fr)
SE (2) SE440025B (fr)
SU (1) SU1158030A3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH027925B2 (fr) * 1978-10-02 1990-02-21 Purdue Research Foundation
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
JPS58157711A (ja) * 1982-03-12 1983-09-19 Kuraray Co Ltd 歯面保護用塗布剤
ATE47519T1 (de) * 1982-07-08 1989-11-15 Leo Ab Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung.
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
JPS59167521A (ja) * 1983-03-14 1984-09-21 Shin Etsu Chem Co Ltd 腸溶性コ−テイング剤組成物
JPS59190925A (ja) * 1983-04-12 1984-10-29 Shin Etsu Chem Co Ltd 腸溶性コ−テイング剤組成物
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
US4587069A (en) * 1983-10-31 1986-05-06 Twinoak Products, Inc. Process for producing color display means
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
GB8707740D0 (en) * 1987-04-01 1987-05-07 Strathclyde Minerals Ltd Composition
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818
EP0542926B1 (fr) * 1990-08-07 1995-02-15 Pfizer Inc. Emploi de membranes a polymerisation interfaciale dans des dispositifs de liberation
JP4644397B2 (ja) * 2001-09-05 2011-03-02 信越化学工業株式会社 難溶性薬物を含む医薬用固形製剤の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK93751C (da) * 1959-02-18 1962-06-25 Abbott Lab Fremgangsmåde til overtrækning af tabletter og flydende blanding til brug ved fremgangsmåden.
DK92805C (da) * 1959-02-18 1962-02-19 Abbott Lab Fremgangsmåde til belægning af tabletter og lignende faste medikamenter og flydende blanding til anvendelse ved fremgangsmåden.
DK100254C (da) * 1961-06-13 1964-11-09 Abbott Lab Overtrækningsmiddel til tabletter.
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
FR1534254A (fr) * 1966-08-16 1968-07-26 Phytogen Products Procédé pour bloquer et favoriser l'oestrus et produit de blocage
DE1617351A1 (fr) * 1967-06-28 1972-01-05
SE324859B (fr) * 1967-09-04 1970-06-15 Ercopharm As
US3655129A (en) * 1968-07-17 1972-04-11 Ppg Industries Inc Slow release films and methods of making same
GB1276089A (en) * 1968-08-23 1972-06-01 Pfizer Ltd Pharmaceutical preparations
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
GB1425550A (en) * 1973-04-25 1976-02-18 Alza Corp Device for releasing active agent and process for producing the same
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
US3946106A (en) * 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device

Also Published As

Publication number Publication date
IL52936A0 (en) 1977-11-30
NO148802B (no) 1983-09-12
NL7710182A (nl) 1978-03-21
SE8300577L (sv) 1983-02-03
AU515157B2 (en) 1981-03-19
ES462418A1 (es) 1978-12-01
SE8300577D0 (sv) 1983-02-03
SE448061B (sv) 1987-01-19
GB1593062A (en) 1981-07-15
JPS5362822A (en) 1978-06-05
AU2878077A (en) 1979-03-22
ATA665877A (de) 1979-08-15
CA1110166A (fr) 1981-10-06
CH634748A5 (de) 1983-02-28
DK152831C (da) 1988-11-07
AT355726B (de) 1980-03-25
NO773187L (no) 1978-03-20
US4267138A (en) 1981-05-12
DD137669A5 (de) 1979-09-19
HU174057B (hu) 1979-10-28
DE2741755C2 (de) 1986-09-25
FI772719A (fi) 1978-03-18
IL52936A (en) 1981-06-29
SU1158030A3 (ru) 1985-05-23
SE440025B (sv) 1985-07-15
FI65911B (fi) 1984-04-30
DE2741755A1 (de) 1978-03-23
FR2364660A1 (fr) 1978-04-14
DK152831B (da) 1988-05-24
JPS6037093B2 (ja) 1985-08-24
FR2364660B1 (fr) 1982-12-10
DK409177A (da) 1978-03-18
NO148802C (no) 1983-12-21
BE858797A (fr) 1978-01-16

Similar Documents

Publication Publication Date Title
FI65911C (fi) Oeverdrag som garanterar en kontrollerad frigoering av aktiva bestaondsdelar ur biologiskt aktiva preparat speciellt ur famaceutiska preparat och foerfarande foer framstaellning a v iologiskt aktiva preparat ur vilka aktiva bestaondsdelar ifroers kontrollerad
FI87042C (fi) Foerfarande foer framstaellning av kontrollerat frigivna laekemedelspreparat
JP4703470B2 (ja) エチルセルローズ水性分散液で被覆した放出制御製剤
US5149542A (en) Coating membrane and compositions prepared therefrom
US5871776A (en) Controlled-release nifedipine
US5876752A (en) Use of interfacially-polymerized membranes in delivery devices
EP0250374B1 (fr) Système thérapeutique avec délivrance contrôlée de médicaments
HUE032182T2 (en) Preparation of controlled release skeletal muscle relaxant dosage forms
CA2000932C (fr) Forme pharmaceutique orale multiparticulaire a liberation controlee
Kibria et al. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D
Yuen et al. Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation
KR100582350B1 (ko) 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제
Muhammad et al. Modifying the release properties of Eudragit® L30D
KR20050071376A (ko) 액체 활성성분 제제를 포함하고 팽창성 삼투 조성물에의해 그의 방출을 제어하는 경구제형
CA2796884A1 (fr) Forme posologique orale a liberation regulee amelioree
KR940008415B1 (ko) 코팅 막과 그로부터 제조된 조성물
JP5146859B2 (ja) アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
Marini et al. Some factors affecting the release of drug from membrane coated slow release tablets
JPH08175977A (ja) アクリル系ポリマーの水性分散液で被覆した放出制御型製剤及びその製法
Aboutaleb et al. Formulation and evaluation of tetracaine hydrochloride polymeric films for topical application
Bruce Influence of drug-polymer interactions on the processing and functionality of anionic polymeric targeted drug delivery systems
JP2008024708A (ja) アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
NO179478B (no) Fremgangsmåte for fremstilling av multiple enheter med overtrekk som inneholder poredanner

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RICHTER GEDEON VEGYESZETI GYOER R.T.